Biological studies to test specific mutations found in ASPP2 in cancer and elucidating the substrates and specific phospho-residues targeted by the ASPP2/PP1 complex will therefore provide new insights into the tumour suppressor role of ASPP2 and might help develop new approaches to cancer treatment. Here, TP53BP2 is linked to neoplasm.